INC launches new consulting unit; Chemi says a saboteur got it banned in Canada;

> INC Research has launched a new business unit, Research Strategic Advisory Services, aimed to consult with drugmakers as they plot paths for development and commercialization. News

> Catalent is extending its partnership with Exelixis to supply the cancer drug CometriqT in the U.S. Story

> U.K. CMO Aesica Pharmaceutical says partnering with academia is getting more and more important for contractors looking to meet the changing demands of pharma clients. Article

> As drug delivery technology moves forward into new frontiers, CROs and CMOs are driving some of the most innovative thinking, Life Science Leader reports. More

> Canada's Chemi Pharmaceutical is blaming a sabotaging former employee for falsified results that got it suspended by the country's regulatory outfit. Item

> QPS has launched a joint venture with Intellim to create a new Japanese CRO. Report

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.